微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 11.7% | 4.37% | 56.63% | 18/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 7.47% | 1.08% | 86.28% | 20/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 4.01% | 0.5% | -70.21% | 13/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 13.46% | -1.75% | 20.07% | 17/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 11.21% | -1.58% | 51.69% | 18/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 7.39% | -0.14% | 85.21% | 18/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 3.99% | -4.32% | -70.88% | 19/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 13.7% | -2.35% | 20.28% | 22/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 11.39% | -7.25% | 53.92% | 25/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 7.4% | -5.61% | 77.46% | 25/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 4.17% | -17.26% | -70.28% | 18/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 14.03% | -22.27% | 14.25% | 24/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 12.28% | -30.58% | 56.63% | 19/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 7.84% | -26.45% | 55.56% | 28/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 5.04% | -43.31% | -72.08% | 13/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 18.05% | -22.03% | 2.04% | 26/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 17.69% | -12.16% | 65.95% | 10/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 10.66% | -22.42% | 19.91% | 16/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 8.89% | 6.47% | -61.6% | 4/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 23.15% | -5.63% | 14.95% | 13/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 20.14% | 0.9% | 46.58% | 5/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 13.74% | -2.14% | 64.55% | 4/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 8.35% | 10.45% | -65.96% | 3/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 24.53% | 8.97% | 22.9% | 5/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 19.96% | 3.63% | 42.17% | 2/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 14.04% | 4.7% | 85.71% | 2/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 7.56% | 5% | -66.41% | 4/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 22.51% | 3.97% | 16.87% | 7/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 19.26% | 3.94% | 43.62% | 7/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 13.41% | 3.47% | 86.25% | 4/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 7.2% | -8.98% | -66.74% | 1/160 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 21.65% | -48.12% | 16.84% | 20/160 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 18.53% | -49.88% | 42.98% | 7/160 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 12.96% | -51.33% | 63.84% | 3/160 | 3.53% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 7.91% | -43.9% | -81.04% | 4/160 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 41.73% | 40.98% | 12.88% | 4/160 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 36.97% | 74.8% | 38.83% | 1/160 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 26.63% | 89.4% | 88.87% | 1/160 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 14.1% | 87% | -52.36% | 2/160 | 2.41% | 华东医药 | 26.63% | 行业排名> |